Posted On: 06/28/2016 11:21:00 AM
Post# of 72441
I find it interesting that Dr. Reddy's makes Brilacidin for CTIX and also has interest in psoriasis (see below). Could it be that the firm that showed previous interest in Prurisol is Dr. Reddy's?
In 2015, Dr. Reddy's Laboratories bought the established brands of Belgian drugmaker UCB SA in South Asia for 8 billion rupees ($128.38 million).[11] Dr. Reddy's Laboratories also signed a licensing pact with XenoPort for their experimental treatment to treat plaque psoriasis. As per the agreement, Dr. Reddy’s will be granted exclusive US rights to develop and commercialize XP23829 for all indications for an upfront payment of $47.5 million. [12]
In 2015, Dr. Reddy's Laboratories bought the established brands of Belgian drugmaker UCB SA in South Asia for 8 billion rupees ($128.38 million).[11] Dr. Reddy's Laboratories also signed a licensing pact with XenoPort for their experimental treatment to treat plaque psoriasis. As per the agreement, Dr. Reddy’s will be granted exclusive US rights to develop and commercialize XP23829 for all indications for an upfront payment of $47.5 million. [12]
(0)
(0)Scroll down for more posts ▼
